Editor: Peter J Levitas
Intellectual Property & Antitrust addresses the most important issues and gives “first step” advice from local experts, covering such areas as: intellectual property law and competition law, IP enforcement proceedings, merger analysis, challenges and behavioural and structural remedies involving IP rights, jurisdiction of competition and IP agencies, cartels, price maintenance, abuse of dominance and remedies.
Pharma & Medical Device Regulation provides a timely and comprehensive overview of the latest legislative and regulatory develops affecting this rapidly changing industry. Topics covered include: health services framework and competent authorities; clinical practice; marketing authorisation; amending authorisations; recall’ promotion; enforcement of advertising rules; pricing and reimbursement; off-label use and unlicensed products and sale and supply.
Editor: Daniel A. Kracov
The pharmaceutical business is truly one of the most global industries, with many companies operating in dozens of countries with differing legal regimes and healthcare systems. In certain respects, the rules governing industry activities have largely become harmonised. However, in other areas the legal frameworks differ. Our objective in framing this volume is to give practitioners in the field a one-volume introduction to critical issues in an array of jurisdictions.